Digoxin vs. Pradaxa: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Digoxin and Pradaxa. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 201,005 people who take Digoxin and Pradaxa, and is updated regularly.
What is Digoxin?
Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.
What is Pradaxa?
Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
201,005 people who take Digoxin and Pradaxa are studied.
Drugs being compared in this study:
- Digoxin (digoxin)
- Pradaxa (dabigatran etexilate mesylate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Digoxin:
- not at all: 2.9 %
- somewhat: 17.88 %
- moderate: 34.51 %
- high: 31.86 %
- very high: 12.85 %
Pradaxa:
- not at all: 3.31 %
- somewhat: 9.69 %
- moderate: 30.5 %
- high: 43.26 %
- very high: 13.24 %
Want to compare Digoxin with Pradaxa?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Digoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pradaxa:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on digoxin and dabigatran etexilate mesylate (the active ingredients of Digoxin and Pradaxa, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Insulin and Gastroesophageal Reflux Disease for Women aged 40-49 - 10 seconds ago
- Insulin and Gastro-Oesophageal Reflux Disease for Women aged 40-49 - 10 seconds ago
- Insulin and Reflux for Women aged 40-49 - 10 seconds ago
- Insulin and Heartburn for Women aged 40-49 - 11 seconds ago
- Insulin and Non-Cardiac Chest Pain for Women aged 40-49 - 11 seconds ago
- Insulin and Gerds for Women aged 40-49 - 11 seconds ago
- Insulin and Acid Reflux for Women aged 40-49 - 12 seconds ago
- Insulin and Reflux Esophagitis for Women aged 40-49 - 12 seconds ago
- Insulin and Pyrosis for Women aged 40-49 - 12 seconds ago
- Insulin and Peptic Esophagitis for Women aged 40-49 - 12 seconds ago